Third Annual Personalized Cancer Vaccines Conference

Recent developments in personalized cancer vaccines are enabling the next generation of rational cancer immunotherapy. Cancer vaccines now may be combined with other immunotherapies, dendritic cells used for personalized immunotherapy, and neoantigens on the surface of cancer cells targeted, matching vaccine components to each patient. mRNA- and DNA-based vaccines present an additional opportunity for cancer therapeutics. Cambridge Healthtech Institute’s Third Annual Personalized Cancer Vaccines meeting will cover applications in several types of cancer and the progress in the understanding of the immune system that has significantly advanced the potential of cancer vaccines.